Asia Pacific Bone Grafts & Substitutes Market to 2027 by Product (Allograft, Synthetic) & Application (Spinal Fusion, Dental, Craniomaxillofacial, Foot & Ankle, Joint Reconstruction, Long Bone)
News provided by
Share this article
Share this article
Asia Pacific Bone Grafts & Substitutes Market Growth & Trends
The Asia Pacific bone grafts and substitutes market size is expected to reach USD 922.4 million by 2027, expanding at a CAGR of 7.1%.
Increasing the incidence of bone disorders due to road accidents and sports injuries is driving the market. Increasing demand for the development of biocompatible bone grafts in order to reduce adverse reaction is driving demand for synthetic grafts.
The industry players are continuously trying to develop new products with better biocompatibility, bioactivity, and suitable mechanical properties. For instance, in June 2019, Biogennix received 510(K) clearance from USFDA for Agilon, which is fully biocompatible with human bone.
Share this article
Share this article
ResearchAndMarkets.com s offering.
The orthopaedic devices global market is expected to reach $53,607.2 million by 2027 growing at a high single digit CAGR.
Over the decade, due to the technological advancements with emerging and innovative technologies used under minimally invasive conditions has led to the rapid development of orthopaedic device. As a result of rapid advances, there is great expansion in the potential therapeutic application for musculoskeletal injuries, deformities and diseases.
The market is primarily driven by the increase in incidence and prevalence of musculoskeletal diseases such as osteoarthritis, osteoporosis, spinal degenerative diseases, spondylitis, lower back pain, herniated spinal discs, and injuries due to trauma and sports activities, increase in the aging population, technological advancement, acquisitions and factors such as product recall, complications associated with implanted devices, lack of skilled
Spine Biologics Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027 Published: Dec. 29, 2020 at 9:06 a.m. ET
The MarketWatch News Department was not involved in the creation of this content.
Dec 29, 2020 (Market Insight Reports)
The Global Spine Biologics Market is estimated to value over USD 2.9 billion by 2027 end at a CAGR of over 4.2% during the forecast period 2020 to 2027.
The research report titled Spine Biologics offers comprehensive information on key driving factors, pricing analysis, market growth trends, brand positioning, competitive landscape, product usage and consumer psyche. This report provides an extensive analysis on market segmentation, strategies for prominent players and market overview. The market overview consists of important parameters extracted from different government bodies, industry and trade associations, information brokers, key companies and other such organizations. The insights obtai